USPTO Examiner HWU JUNE - Art Unit 1661

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18831801Miniature Rose Plant Named 'Poulpal097'September 2025March 2026Allow610YesNo
19315655Chamaecyparis Plant Named 'Edengra 23'September 2025November 2025Allow200NoNo
19313647MANDEVILLA PLANT NAMED 'TVMD1232'August 2025October 2025Allow200NoNo
19313635MANDEVILLA PLANT NAMED 'TVMD1143'August 2025October 2025Allow200NoNo
19243676PHALAENOPSIS PLANT NAMED 'AMAZE'June 2025October 2025Allow400NoNo
19243678PHALAENOPSIS PLANT NAMED 'CORONADO'June 2025October 2025Allow400NoNo
19240799MANDEVILLA PLANT NAMED 'QD-94'June 2025September 2025Allow300NoNo
19240756MANDEVILLA PLANT NAMED 'QD-36'June 2025November 2025Allow500NoNo
19240782MANDEVILLA PLANT NAMED 'QD-80'June 2025September 2025Allow300NoNo
19240819MANDEVILLA PLANT NAMED 'QD-123'June 2025September 2025Allow300NoNo
18831619NEPETA PLANT NAMED 'LEMON PURRFECTION'June 2025December 2025Allow610NoNo
19235266Murdannia Plant Named 'EC-MURD-2504'June 2025September 2025Allow400NoNo
19235130Echinacea Plant Named 'BullEchipur 119'June 2025February 2026Allow810NoNo
19235107Echinacea Plant Named 'BullEchipur 118'June 2025February 2026Allow810NoNo
19208197Hybrid Lavender Plant Named 'SENS-M1'May 2025November 2025Allow610NoNo
19194392Haworthia Plant Named 'Lizard King'April 2025September 2025Allow510NoNo
18831575Ceropegia Plant Named 'LUUK'April 2025December 2025Allow810NoNo
18831571Dianthus Plant Named 'Whipped Cream'April 2025November 2025Allow710NoNo
19187105GUAYULE PLANT NAMED 'E-B2WN-13167'April 2025January 2026Allow910NoNo
19187579Pelargonium Plant Named 'KLEPZ24789'April 2025December 2025Allow710NoNo
19186398ECHINACEA PLANT NAMED 'TNECHFT'April 2025October 2025Allow610NoNo
19183793ALOCASIA PLANT NAMED 'WHITE DRAGON'April 2025August 2025Allow410NoNo
19182900MANDARIN PLANT NAMED 'Mikanken10'April 2025September 2025Allow510NoNo
18831559Philodendron Plant Named 'HUTAPD75'April 2025August 2025Allow400NoNo
18831560Gasteraloe Plant Named 'OVROCKS15'April 2025December 2025Allow810NoNo
19174184Oyster Mushroom Variety Named 'WUR SF3'April 2025December 2025Allow810NoNo
18831536Aristeria plant named 'OVROCKS13'April 2025July 2025Allow300NoNo
19170269MUSCADINE GRAPE PLANT NAMED 'USDA-ARS-BERTHA MAE'April 2025September 2025Allow510NoNo
19087571Hibiscus Plant Named 'Tahi2025'March 2025October 2025Allow610NoNo
19083810Chionanthus Tree Named 'CRMTF'March 2025September 2025Allow610NoNo
19070802Fragaria Plant Named 'PGP182'March 2025September 2025Allow610NoNo
19057187Cotinus Plant Named ‘Kolmagipur'February 2025September 2025Allow710NoNo
19057128METHODS OF IMPROVING STRESS TOLERANCE, GROWTH AND YIELD IN PLANTSFebruary 2025November 2025Allow910NoNo
19054359PETUNIA PLANT NAMED 'DOPETPOTYEL 25'February 2025September 2025Allow710NoNo
19054438PETUNIA PLANT NAMED 'DOPETSURSPABLUVEI'February 2025September 2025Allow710NoNo
19053365STRAWBERRY PLANT NAMED 'PE-14.250.070'February 2025September 2025Allow710NoNo
19049975Shrub Rose Plant Named 'AUSCP18729'February 2025August 2025Allow610NoNo
19048472Buddleja Plant Named 'SFF22-053'February 2025September 2025Allow710NoNo
18831463Buddleia Plant Named ‘Cherry Royale’January 2025August 2025Allow710NoNo
19037198SALVIA PLANT NAMED 'DH002'January 2025August 2025Allow710NoNo
19037025CITRUS L. PLANT NAMED 'HAYASE'January 2025October 2025Allow910NoNo
19036991Hydrangea Plant Named 'GRHYAR2008'January 2025July 2025Allow610NoNo
19037008Rudbeckia Plant Named 'RUDBCHR650'January 2025August 2025Allow710NoNo
18831410Philodendron Plant Named 'WHIWAMIN'January 2025December 2025Allow1000NoNo
19032725Caladium Plant Named 'UF-R301'January 2025July 2025Allow610NoNo
19030145HYDRANGEA PLANT NAMED 'HORE9311'January 2025December 2025Allow1120NoNo
19028225Dahlia Plant Named 'LeeAnn's BA67C'January 2025July 2025Allow610NoNo
19025516Grapevine Plant Named 'MN 1369'January 2025April 2025Allow300NoNo
19025391Hemerocallis Plant Named 'G221407'January 2025July 2025Allow610NoNo
19022499Climbing Rose Plant Named 'ALTenglanda'January 2025July 2025Allow610NoNo
19016868Distylium Plant Named 'ZhDis12-16'January 2025August 2025Allow700NoNo
19016915Thuja Plant Named 'RutThu7'January 2025July 2025Allow710NoNo
19010890Poinsettia Plant Named 'NPCW24408'January 2025October 2025Allow920NoNo
19005074Hybrid Tea Rose Plant Named 'KORpanimar'December 2024July 2025Allow610NoNo
19006005CHRYSANTHEMUM PLANT NAMED 'G24BRA14RE'December 2024May 2025Allow400NoNo
19001010STRAWBERRY PLANT NAMED 'HOB-R490'December 2024July 2025Allow710NoNo
18999438Dahlia Plant Named 'LeeAnn's FD61A'December 2024August 2025Allow810NoNo
19000680Sansevieria Plant Named 'Hansoti59'December 2024July 2025Allow710NoNo
18989662GRAPEVINE PLANT NAMED 'BLOMG01'December 2024June 2025Allow510NoNo
18831373Hosta Plant Named 'Avant Garde'December 2024October 2025Allow910NoNo
18988701STRAWBERRY PLANT NAMED ‘Emerald'December 2024July 2025Allow710NoNo
18981531GYPSOPHILA PLANT NAMED 'ESM G057'December 2024March 2025Allow300NoNo
18980088GRAPEVINE PLANT NAMED 'IVC AN1'December 2024October 2025Allow1020NoNo
18978140Bedding Rose Plant Named 'MEISOBUKO'December 2024August 2025Allow820YesNo
18978293Paeonia Plant Named 'Smithopus3'December 2024June 2025Allow610NoNo
18976959Agapanthus Plant Named 'FO21WM111'December 2024June 2025Allow610NoNo
18977478SHRUB ROSE PLANT NAMED 'CHEWGOLDRUSH'December 2024November 2025Allow1110NoNo
18967936Petunia Plant Named 'DPETCPFCLC'December 2024November 2025Allow1110NoNo
18966383Paeonia plant named 'Smithopus5'December 2024June 2025Allow610NoNo
18964969Hydrangea Plant Named 'SMNHPLK'December 2024October 2025Allow1110NoNo
18964922Calycanthus Plant Named 'PRNCFS'December 2024October 2025Allow1110NoNo
18966052Hosta Plant Named 'NK2021'December 2024April 2025Allow410NoNo
18964279Rubus Idaeus Plant Named 'BT RASseven'November 2024June 2025Allow710NoNo
18963927STRAWBERRY PLANT VARIETY NAMED 'GOLD BERRY'November 2024July 2025Allow710NoNo
18831347Heucherella plant named 'Shadow Tag'November 2024November 2025Allow1120NoNo
18956628PETUNIA PLANT NAMED 'WNPETSVCJ26'November 2024May 2025Allow600NoNo
18831338Echinacea Plant Named 'Everything's Rosy'November 2024February 2025Allow300NoNo
18955409PERSEA AMERICANA PLANT NAMED 'BeeOne'November 2024June 2025Allow710NoNo
18831328Aloe Plant Named 'AMIAL2136'November 2024June 2025Allow710NoNo
18920672Dasiphora Plant Named 'Bailpine’October 2024April 2025Allow600NoNo
18912712Buddleja Plant Named 'Botex 010'October 2024April 2025Allow610NoNo
18913349Cortaderia Plant Named 'Day20'October 2024June 2025Allow810NoNo
18911938PHLOX PLANT NAMED 'BALSASHAC'October 2024October 2025Allow1320NoNo
18910848CHERRY PLUM TREE NAMED ‘FARMER 3-01'October 2024July 2025Allow910NoNo
18910764CHERRY PLUM TREE NAMED ‘FARMER 8-04’October 2024November 2025Allow1310NoNo
18909307Apple Tree Named 'PremA047'October 2024April 2025Allow610NoNo
18902526CANNABIS PLANT NAMED 'PTC8510V'September 2024May 2025Allow710NoNo
18897672SENECIO PLANT NAMED 'SENE ISIFURO'September 2024June 2025Allow910NoNo
18885323BLUEBERRY PLANT NAMED ‘CBG-23-05’September 2024July 2025Allow1010NoNo
18827722Viburnum Plant Named 'Bailvibone'September 2024April 2025Allow800NoNo
18831190Miniature Rose Plant Named 'Poulvic011'September 2024December 2024Allow300NoNo
18831186Floribunda Rose Plant Named 'Poulnap008'September 2024February 2025Allow610NoNo
18815996Calla Lily Plant Named 'Dozanwhamb'August 2024January 2025Allow400NoNo
18831163Grapevine Plant Named 'SV34-130-92'August 2024May 2025Allow910NoNo
18808076Clematis Plant Named 'Zo23015'August 2024December 2024Allow300NoNo
18809077Clematis Plant Named 'Violet Lampion'August 2024November 2025Allow1510NoNo
18808029MANDEVILLA PLANT NAMED 'TVMD1141'August 2024March 2025Allow710NoNo
18831136Geum Plant Named 'MACGEU050'August 2024December 2025Allow1620NoNo
18799889Distylium Plant Named 'EH-60-22'August 2024May 2025Allow920NoNo
18799927Cercis Plant Named 'JN31'August 2024August 2025Allow1310NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HWU, JUNE.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
7
(87.5%)
Examiner Reversed
1
(12.5%)
Reversal Percentile
24.7%
Lower than average

What This Means

With a 12.5% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
31
Allowed After Appeal Filing
5
(16.1%)
Not Allowed After Appeal Filing
26
(83.9%)
Filing Benefit Percentile
18.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 16.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner HWU, JUNE - Prosecution Strategy Guide

Executive Summary

Examiner HWU, JUNE works in Art Unit 1661 and has examined 3,507 patent applications in our dataset. With an allowance rate of 94.2%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 15 months.

Allowance Patterns

Examiner HWU, JUNE's allowance rate of 94.2% places them in the 82% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by HWU, JUNE receive 0.72 office actions before reaching final disposition. This places the examiner in the 4% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HWU, JUNE is 15 months. This places the examiner in the 99% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -9.8% benefit to allowance rate for applications examined by HWU, JUNE. This interview benefit is in the 3% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 19.3% of applications are subsequently allowed. This success rate is in the 20% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 64.2% of cases where such amendments are filed. This entry rate is in the 88% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 70% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 52.9% of appeals filed. This is in the 23% percentile among all examiners. Of these withdrawals, 55.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 82.9% are granted (fully or in part). This grant rate is in the 86% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 19.1% of allowed cases (in the 98% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.1% of allowed cases (in the 52% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.